Meiwei Biological (688062.SH): 13,590 shares of the company's stock were repurchased for the first time through centralized bidding on September 18th.
Merway Biological (688062.SH) announced that on September 18, 2025, the company completed a transaction through centralized competitive bidding...
Meiwei Biotech (688062.SH) announced that on September 18, 2025, the company repurchased 135,938 shares through centralized bidding trading for the first time, accounting for approximately 0.03% of the total share capital of the company. The highest price of the repurchase transaction was 58.02 yuan per share, the lowest price was 52.79 yuan per share, and the total amount paid was 7.3614 million yuan.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


